EGFR and cancer: Seven commonly studied cancer biomarkers were selected: TP53, PTEN, KRAS, MSI, IDH1, EGFR, and BRAF. The results of the Kaplan–Meier analyses for patients without and with specific biomarker alterations are presented in Fig. 5a and Fig. 5b, respectively.